Frequency of occurrence of Anemia ≥ grade 3;Frequency of occurrence of CPK increase ≥ grade 3;Percentage of patients with ECG abnormalities.;Percentage of patients with serious adverse events.;Frequency of occurrence of Increase ALT and / or AST ≥ grade 3;Frequency of occurrence of Increase total bilirubin or direct bilirubin ≥ grade 3;Frequency of occurrence of Neutropenia ≥ grade 3;Percentage of patients with adverse events.;Frequency of occurrence of Thrombocytopenia ≥ grade 3;Frequency of occurrence of Lymphopenia ≥ grade 3;Frequency of occurrence of QT-QTc interval extension ≥ grade 3;Frequency of occurrence of Neurotoxicity ≥ grade 3;Percentage of patients in whom treatment cannot be completed.;Frequency of occurrence of Other adverse events ≥ grade 3

Frequency of occurrence of Anemia ≥ grade 3;Frequency of occurrence of CPK increase ≥ grade 3;Percentage of patients with ECG abnormalities.;Percentage of patients with serious adverse events.;Frequency of occurrence of Increase ALT and / or AST ≥ grade 3;Frequency of occurrence of Increase total bilirubin or direct bilirubin ≥ grade 3;Frequency of occurrence of Neutropenia ≥ grade 3;Percentage of patients with adverse events.;Frequency of occurrence of Thrombocytopenia ≥ grade 3;Frequency of occurrence of Lymphopenia ≥ grade 3;Frequency of occurrence of QT-QTc interval extension ≥ grade 3;Frequency of occurrence of Neurotoxicity ≥ grade 3;Percentage of patients in whom treatment cannot be completed.;Frequency of occurrence of Other adverse events ≥ grade 3